Citation Impact
Citing Papers
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
2010
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma
2008
TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells
2016
Increased Dickkopf-1 expression in breast cancer bone metastases
2007
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
2001
Regulation of stress‐activated protein kinase signaling pathways by protein phosphatases
2002
Involvement of Members of the Cadherin Superfamily in Cancer
2009
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
SHH Pathway and Cerebellar Development
2009
Medulloblastomics: the end of the beginning
2012
Apc deficiency predisposes to renal carcinoma in the mouse
2005
Hepatocellular carcinoma
2016 Standout
Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1
2010 Standout
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
2007
Cancer to bone: a fatal attraction
2011 Standout
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
2006
Expression and functional role of negative signalling regulators in tumour development and progression
2010
AP-1: a double-edged sword in tumorigenesis
2003 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
2008 Standout
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
The Molecular Signatures Database Hallmark Gene Set Collection
2015 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
2013
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
2014 Standout
Canonical and Noncanonical Hedgehog/GLI Signaling in Hematological Malignancies
2012
Ubiquitin ligases: cell-cycle control and cancer
2006
AP-1 as a regulator of cell life and death
2002 Standout
Disruption of the mouse protein Ser/Thr phosphatase 2Cβ gene leads to early pre-implantation lethality
2007 StandoutNobel
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
2010 StandoutNobel
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cellular Responses to Cisplatin‐Induced DNA Damage
2010
p21 in cancer: intricate networks and multiple activities
2009 Standout
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
2012
Regulation of MAP kinases by MAP kinase phosphatases
2006
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Deficiency of SPARC suppresses intestinal tumorigenesis in APC Min/+ mice
2007 StandoutNobel
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
2002
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Reflecting on 25 years with MYC
2008 Standout
DUSPs, to MAP kinases and beyond
2012
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
2014
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
2011
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
2013 Standout
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
2008
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Cancer-related inflammation and treatment effectiveness
2014 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Gene Expression Profiling of Neural Stem Cells and Their Neuronal Progeny Reveals IGF2 as a Regulator of Adult Hippocampal Neurogenesis
2012
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Environmental epigenomics and disease susceptibility
2007 Standout
The primary cilium: a signalling centre during vertebrate development
2010 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
2011
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Management of glioblastoma: State of the art and future directions
2020 Standout
Imbalanced genomic imprinting in brain development: an evolutionary basis for the aetiology of autism
2006
The MAPK pathway across different malignancies: A new perspective
2014 Standout
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The MAX-interacting transcription factor network
2006
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Mnt Takes Control as Key Regulator of the Myc/Max/Mxd Network
2007
Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
2008
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
The Max Network Gone Mad
2001
NF‐κB and the link between inflammation and cancer
2012
Medulloblastoma Stem Cells
2008
Neurogenesis at the Brain–Cerebrospinal Fluid Interface
2011
Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis
2012
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Works of Anke Waha being referenced
Epigenetic Downregulation of Mitogen-Activated Protein Kinase Phosphatase MKP-2 Relieves Its Growth Suppressive Activity in Glioma Cells
2010
Activation of Phosphatidylinositol-3′-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival
2009
Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in Astrocytomas
2005
Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas
2012
Identification and characterization of genes upregulated in cells transformed by v-Jun
2000
Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts
2001
Analysis of the max-binding protein MNT in human medulloblastomas
1999
Insulin-Like Growth Factor II Is Involved in the Proliferation Control of Medulloblastoma and Its Cerebellar Precursor Cells
2005
Overexpression of Human Dickkopf-1, an Antagonist of wingless/WNT Signaling, in Human Hepatoblastomas and Wilms' Tumors
2003
Epigenetic Silencing of theHIC-1Gene in Human Medulloblastomas
2003
Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF‐dependent transcription in medulloblastomas
2007
Phosphatidylinositol 3′-Kinase/AKT Signaling Is Activated in Medulloblastoma Cell Proliferation and Is Associated with Reduced Expression of PTEN
2006
Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas
2005